	OR

Email Id:	*(Required)
Password:
	Remember Me	Reset Password?
	Note: Please enter emailid to receive instructions to reset password.

	Not A Member Yet ? Sign Up

(Quarter Update)

Buy

At Price: Rs 108

Target: Rs 168

Result Update -- KR Choksey

Filatex India Limited (FIL) reported revenue growth of 27.8% YoY/1.5% QoQ to INR 10,900 Mn in Q4FY22.

Report Date June 3, 2022

(Quarter Update)

ACCUMULATE

At Price: Rs 533

Target: Rs 605

Result Update -- KR Choksey

Aurobindo reported Revenue de-growth of -3.2% YoY (-3.2% QoQ) to INR 58.09 bn due to 4.7% YoY (-0.6% QoQ) decline in the US’ revenue (47.0% of revenue), 52.0% YoY (+51.5% QoQ) decline in ARV sales (4.1% of revenue) and a 0.8% YoY (-9.1% QoQ) decline in Europe revenue (26.5% of revenue); partially offset by 28.0% YoY (-1.4% QoQ) rise in growth market revenue (6.7% of revenue) and 14.9% YoY (-9.6% QoQ) rise in API revenue (15.7% of revenue)

More..

Report Date June 3, 2022

(Quarter Update)

Buy

At Price: Rs 861

Target: Rs 1074

Result Update -- KR Choksey

Sun Pharma reported revenue growth of 10.8% YoY (-4.2% QoQ) to INR 94,468 mn.

Report Date June 1, 2022

(Quarter Update)

Buy

At Price: Rs 811

Target: Rs 1094

Result Update -- KR Choksey

In Q4FY22, Aarti Industries’ revenue grew 45.2% YoY to INR 17,556 mn supported by better realization due to the company’s ability to pass on the hike in raw material prices albeit with a time lag as well as volume expansion. Though on sequential basis, revenue declined by 26.1% QoQ on account of high base as Q3FY22 included termination fees of INR 6.3 bn for the 1 st long term contract. For FY22 revenue witnessed robust growth of 55.3% YoY to INR 70,000 mn.

More..

Report Date May 31, 2022

(Quarter Update)

ACCUMULATE

At Price: Rs 1592

Target: Rs 1802

Result Update -- KR Choksey

For Q4FY22, Colgate-Palmolive Ltd. reported revenue growth of 1.4% YoY (1.7% QoQ) to INR 13,013 Mn. For FY22 revenues stood at INR 50.998 Mn, up by 5.3% from FY21.

Report Date May 30, 2022

(Quarter Update)

Buy

At Price: Rs 889

Target: Rs 1180

Result Update -- KR Choksey

Revenue reported at INR 24,151Mn (+7.9% yoy / +10.7% qoq) in the midst of semiconductor shortage and inflationary pressures due to geopolitical tensions. In terms of business segments, revenue contribution from 2Ws and 4Ws stood at 45% / 55%, respectively. Export revenue stood at 16% of overall revenue during the quarter.

More..

Report Date May 26, 2022

by Priyanka Baliga

(Quarter Update)

Buy

At Price: Rs 368

Target: Rs 445

Result Update -- KR Choksey

The company posted a 5.3% YoY (+5.7% QoQ) rise in revenue to INR 38.64 bn. Growth in revenue from operations was driven by 13.8% YoY (+7.9% QoQ) rise in India revenue (31% of revenue) and 5.8% YoY (+65.7% QoQ) rise in India Consumer Wellness revenue (17.0% of revenue) in Q4FY22.

More..

Report Date May 25, 2022

(Quarter Update)

Buy

At Price: Rs 659

Target: Rs 843

Result Update -- KR Choksey

In Q4FY22, Ramco Cement’s revenue grew 4.9% YoY/10.4% QoQ to INR 17,134 mn. Cement sales was mostly flat at 31.92 lac tons for Q4FY22, a decline of 1% YoY from 32.13 lac tons in Q4FY21.

Report Date May 25, 2022

(Quarter Update)

ACCUMULATE

At Price: Rs 21942

Target: Rs 25086

Result Update -- KR Choksey

In Q4FY22, Shree Cement’s revenue grew 3.1% YoY/20% QoQ to INR 43,642 mn, surpassing our estimate by 7.2%. For FY22, revenue grew 10.7% YoY to INR 150,096 Mn.

Report Date May 24, 2022

(Quarter Update)

Buy

At Price: Rs 4275

Target: Rs 5261

Result Update -- KR Choksey

Dr. Reddy’s laboratories reported adj. revenue growth at 10.3% YoY (-1.5% QoQ) to INR 52.59 bn in Q4FY22. This was driven by 10.0% YoY (-0.7% QoQ) increase in revenue from operations to INR 50.68 bn, 26.6% YoY (-29.8% QoQ) decline in license fees and services income to INR 1.52 bn and a 4.3% YoY (+104.8% QoQ) decline in other operating revenue to INR 381.0 mn in Q4FY22.

More..

Report Date May 24, 2022